| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries, Traumatic | 20 | 2023 | 102 | 9.870 |
Why?
|
| Brain Injuries | 24 | 2023 | 167 | 9.030 |
Why?
|
| Intracranial Hypertension | 16 | 2023 | 58 | 6.730 |
Why?
|
| Brain Death | 10 | 2023 | 83 | 5.530 |
Why?
|
| Intracranial Pressure | 18 | 2023 | 88 | 5.110 |
Why?
|
| Cerebrovascular Circulation | 17 | 2023 | 232 | 5.080 |
Why?
|
| Head Injuries, Penetrating | 9 | 2025 | 65 | 4.870 |
Why?
|
| Tissue and Organ Procurement | 8 | 2023 | 364 | 3.840 |
Why?
|
| Monitoring, Physiologic | 13 | 2024 | 265 | 3.060 |
Why?
|
| Critical Care | 16 | 2024 | 385 | 2.670 |
Why?
|
| Consciousness | 4 | 2023 | 28 | 2.490 |
Why?
|
| Decompressive Craniectomy | 5 | 2023 | 19 | 2.480 |
Why?
|
| Tissue Donors | 7 | 2023 | 511 | 2.420 |
Why?
|
| Brain | 16 | 2025 | 2327 | 2.280 |
Why?
|
| Clinical Decision-Making | 4 | 2021 | 283 | 2.230 |
Why?
|
| Death | 7 | 2024 | 90 | 2.130 |
Why?
|
| Cerebral Hemorrhage | 11 | 2022 | 342 | 2.120 |
Why?
|
| Hypoxia, Brain | 4 | 2023 | 43 | 1.850 |
Why?
|
| Consciousness Disorders | 3 | 2023 | 10 | 1.820 |
Why?
|
| Humans | 115 | 2025 | 90568 | 1.760 |
Why?
|
| Judgment | 2 | 2024 | 68 | 1.620 |
Why?
|
| Intensive Care Units | 10 | 2023 | 399 | 1.430 |
Why?
|
| Subarachnoid Hemorrhage | 6 | 2012 | 142 | 1.420 |
Why?
|
| Hematoma | 2 | 2021 | 108 | 1.360 |
Why?
|
| Family | 3 | 2023 | 324 | 1.350 |
Why?
|
| Mental Competency | 2 | 2023 | 49 | 1.310 |
Why?
|
| Coma | 4 | 2023 | 47 | 1.250 |
Why?
|
| Metaphysics | 2 | 2021 | 3 | 1.220 |
Why?
|
| Apnea | 2 | 2020 | 31 | 1.180 |
Why?
|
| Brain Ischemia | 6 | 2021 | 400 | 1.170 |
Why?
|
| Brain Edema | 3 | 2021 | 58 | 1.160 |
Why?
|
| Hemostatics | 2 | 2021 | 58 | 1.130 |
Why?
|
| Neurophysiological Monitoring | 7 | 2023 | 17 | 1.100 |
Why?
|
| Vasospasm, Intracranial | 4 | 2010 | 35 | 1.040 |
Why?
|
| Perfusion | 5 | 2023 | 255 | 1.010 |
Why?
|
| Hypothermia, Induced | 2 | 2016 | 82 | 1.000 |
Why?
|
| Stroke | 8 | 2021 | 1003 | 0.950 |
Why?
|
| Wounds, Gunshot | 3 | 2025 | 110 | 0.950 |
Why?
|
| Arterial Pressure | 2 | 2014 | 38 | 0.910 |
Why?
|
| Elephants | 1 | 2023 | 17 | 0.870 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 846 | 0.850 |
Why?
|
| Personal Autonomy | 1 | 2023 | 116 | 0.840 |
Why?
|
| Patient Preference | 2 | 2021 | 117 | 0.830 |
Why?
|
| Informed Consent | 4 | 2023 | 277 | 0.820 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2023 | 160 | 0.820 |
Why?
|
| Spinal Cord Injuries | 2 | 2014 | 64 | 0.800 |
Why?
|
| Practice Guidelines as Topic | 4 | 2021 | 1054 | 0.790 |
Why?
|
| Decision Making | 4 | 2023 | 672 | 0.780 |
Why?
|
| Oxygen Consumption | 3 | 2023 | 244 | 0.760 |
Why?
|
| Withholding Treatment | 3 | 2021 | 117 | 0.760 |
Why?
|
| Hypoxia | 2 | 2016 | 660 | 0.750 |
Why?
|
| Uncertainty | 2 | 2019 | 75 | 0.740 |
Why?
|
| Vascular System Injuries | 1 | 2021 | 30 | 0.740 |
Why?
|
| Injury Severity Score | 2 | 2021 | 148 | 0.730 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2021 | 12 | 0.730 |
Why?
|
| Length of Stay | 4 | 2023 | 756 | 0.720 |
Why?
|
| Disabled Persons | 1 | 2021 | 72 | 0.720 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 157 | 0.710 |
Why?
|
| Hypocalcemia | 1 | 2020 | 44 | 0.710 |
Why?
|
| Communication | 3 | 2023 | 462 | 0.710 |
Why?
|
| Heart Conduction System | 1 | 2021 | 112 | 0.700 |
Why?
|
| Ventilator Weaning | 2 | 2011 | 24 | 0.700 |
Why?
|
| Oxygen | 5 | 2023 | 747 | 0.700 |
Why?
|
| Amantadine | 1 | 2020 | 18 | 0.700 |
Why?
|
| Critical Illness | 4 | 2017 | 315 | 0.690 |
Why?
|
| Nootropic Agents | 1 | 2020 | 10 | 0.690 |
Why?
|
| Neurosurgical Procedures | 5 | 2023 | 244 | 0.680 |
Why?
|
| Respiration, Artificial | 2 | 2021 | 361 | 0.680 |
Why?
|
| Blood Coagulation Disorders | 1 | 2021 | 66 | 0.670 |
Why?
|
| Life Support Care | 2 | 2021 | 50 | 0.660 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2021 | 150 | 0.660 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 201 | 0.660 |
Why?
|
| Prognosis | 10 | 2021 | 3810 | 0.640 |
Why?
|
| Recovery of Function | 3 | 2020 | 305 | 0.630 |
Why?
|
| Electrocardiography | 1 | 2021 | 498 | 0.620 |
Why?
|
| Heart Rate | 1 | 2021 | 496 | 0.620 |
Why?
|
| Glasgow Coma Scale | 5 | 2023 | 74 | 0.610 |
Why?
|
| Cognition Disorders | 1 | 2020 | 236 | 0.600 |
Why?
|
| Craniocerebral Trauma | 2 | 2020 | 56 | 0.580 |
Why?
|
| Pleasure-Pain Principle | 1 | 2017 | 2 | 0.570 |
Why?
|
| Male | 32 | 2025 | 42931 | 0.570 |
Why?
|
| Brain Neoplasms | 1 | 2023 | 781 | 0.570 |
Why?
|
| Action Potentials | 1 | 2021 | 602 | 0.570 |
Why?
|
| Intracranial Aneurysm | 3 | 2020 | 178 | 0.570 |
Why?
|
| Retrospective Studies | 18 | 2025 | 9323 | 0.560 |
Why?
|
| Workload | 1 | 2018 | 130 | 0.560 |
Why?
|
| Seizures | 1 | 2020 | 308 | 0.560 |
Why?
|
| Suicide, Assisted | 1 | 2017 | 33 | 0.550 |
Why?
|
| Patient Advocacy | 1 | 2017 | 53 | 0.550 |
Why?
|
| Female | 35 | 2025 | 46855 | 0.550 |
Why?
|
| Terminal Care | 1 | 2018 | 137 | 0.550 |
Why?
|
| Heart Arrest | 2 | 2023 | 280 | 0.550 |
Why?
|
| Personal Satisfaction | 1 | 2017 | 64 | 0.540 |
Why?
|
| Shock | 1 | 2016 | 44 | 0.530 |
Why?
|
| Persistent Vegetative State | 1 | 2016 | 9 | 0.530 |
Why?
|
| Saline Solution, Hypertonic | 2 | 2013 | 24 | 0.520 |
Why?
|
| Euthanasia | 1 | 2016 | 16 | 0.520 |
Why?
|
| Mitochondria | 2 | 2016 | 562 | 0.520 |
Why?
|
| Middle Aged | 24 | 2025 | 26327 | 0.500 |
Why?
|
| Hemodynamics | 3 | 2017 | 739 | 0.500 |
Why?
|
| Mind-Body Relations, Metaphysical | 1 | 2015 | 3 | 0.490 |
Why?
|
| Trust | 1 | 2016 | 97 | 0.490 |
Why?
|
| Adult | 21 | 2025 | 26940 | 0.490 |
Why?
|
| Tissue Survival | 1 | 2015 | 13 | 0.480 |
Why?
|
| Social Values | 1 | 2015 | 44 | 0.480 |
Why?
|
| Pyruvic Acid | 1 | 2014 | 12 | 0.480 |
Why?
|
| Central Nervous System Infections | 1 | 2014 | 3 | 0.470 |
Why?
|
| Research Design | 2 | 2015 | 590 | 0.470 |
Why?
|
| Lung | 1 | 2021 | 1305 | 0.460 |
Why?
|
| Cardiovascular System | 1 | 2015 | 63 | 0.460 |
Why?
|
| Lactic Acid | 1 | 2014 | 95 | 0.460 |
Why?
|
| Bioethical Issues | 1 | 2014 | 38 | 0.460 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2014 | 6 | 0.460 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2015 | 79 | 0.460 |
Why?
|
| Touch | 1 | 2015 | 99 | 0.460 |
Why?
|
| Hospital Mortality | 3 | 2025 | 426 | 0.450 |
Why?
|
| Aprotinin | 1 | 2013 | 26 | 0.440 |
Why?
|
| Myelinolysis, Central Pontine | 1 | 2013 | 3 | 0.440 |
Why?
|
| Organ Preservation | 3 | 2023 | 122 | 0.430 |
Why?
|
| Intracranial Hypotension | 1 | 2013 | 3 | 0.430 |
Why?
|
| Respiratory Insufficiency | 1 | 2015 | 163 | 0.420 |
Why?
|
| Spinal Cord | 2 | 2014 | 255 | 0.420 |
Why?
|
| Hypoglycemia | 1 | 2013 | 109 | 0.410 |
Why?
|
| Prospective Studies | 9 | 2022 | 4345 | 0.410 |
Why?
|
| Cerebral Angiography | 6 | 2015 | 197 | 0.400 |
Why?
|
| Treatment Outcome | 11 | 2021 | 8373 | 0.400 |
Why?
|
| Pulsatile Flow | 1 | 2012 | 51 | 0.400 |
Why?
|
| Resuscitation | 2 | 2023 | 111 | 0.400 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2015 | 197 | 0.390 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 651 | 0.390 |
Why?
|
| Airway Extubation | 1 | 2011 | 11 | 0.390 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 604 | 0.380 |
Why?
|
| Risk Assessment | 6 | 2021 | 2335 | 0.380 |
Why?
|
| Tracheostomy | 1 | 2011 | 46 | 0.370 |
Why?
|
| Physicians | 2 | 2020 | 690 | 0.360 |
Why?
|
| Heuristics | 2 | 2020 | 15 | 0.350 |
Why?
|
| Telemedicine | 2 | 2020 | 196 | 0.350 |
Why?
|
| Cerebral Arteries | 1 | 2010 | 74 | 0.340 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2010 | 82 | 0.330 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2025 | 2702 | 0.320 |
Why?
|
| Shock, Cardiogenic | 1 | 2010 | 124 | 0.320 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 482 | 0.310 |
Why?
|
| Risk Factors | 7 | 2022 | 5580 | 0.300 |
Why?
|
| Time Factors | 10 | 2021 | 5365 | 0.290 |
Why?
|
| Nervous System Diseases | 1 | 2009 | 163 | 0.290 |
Why?
|
| Cardiomyopathies | 1 | 2010 | 269 | 0.290 |
Why?
|
| Delphi Technique | 2 | 2024 | 105 | 0.280 |
Why?
|
| Hypernatremia | 1 | 2007 | 9 | 0.280 |
Why?
|
| Predictive Value of Tests | 4 | 2021 | 1741 | 0.280 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 532 | 0.270 |
Why?
|
| Young Adult | 5 | 2025 | 6425 | 0.260 |
Why?
|
| Thrombolytic Therapy | 3 | 2021 | 246 | 0.260 |
Why?
|
| Giant Cell Arteritis | 1 | 2005 | 5 | 0.260 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 476 | 0.260 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2005 | 7 | 0.260 |
Why?
|
| Consensus | 2 | 2024 | 371 | 0.250 |
Why?
|
| Surveys and Questionnaires | 4 | 2023 | 2667 | 0.250 |
Why?
|
| Blood Pressure | 2 | 2023 | 906 | 0.240 |
Why?
|
| Homeostasis | 2 | 2021 | 424 | 0.240 |
Why?
|
| Aged | 11 | 2025 | 19404 | 0.230 |
Why?
|
| Neuroimaging | 1 | 2025 | 126 | 0.220 |
Why?
|
| Regional Blood Flow | 1 | 2023 | 198 | 0.210 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2015 | 176 | 0.210 |
Why?
|
| Comparative Effectiveness Research | 1 | 2023 | 54 | 0.200 |
Why?
|
| Physical Examination | 1 | 2023 | 150 | 0.200 |
Why?
|
| Mortality | 2 | 2020 | 148 | 0.200 |
Why?
|
| Mannitol | 2 | 2013 | 50 | 0.200 |
Why?
|
| Public Opinion | 1 | 2021 | 46 | 0.190 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2012 | 18 | 0.190 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2021 | 52 | 0.180 |
Why?
|
| Diabetes Insipidus, Neurogenic | 1 | 2020 | 4 | 0.180 |
Why?
|
| Hypocapnia | 1 | 2020 | 6 | 0.180 |
Why?
|
| Hypopituitarism | 1 | 2020 | 19 | 0.180 |
Why?
|
| Adrenal Insufficiency | 1 | 2020 | 23 | 0.180 |
Why?
|
| Electrolytes | 1 | 2020 | 52 | 0.180 |
Why?
|
| Tomography Scanners, X-Ray Computed | 3 | 2020 | 22 | 0.180 |
Why?
|
| Clinical Trials as Topic | 3 | 2015 | 1141 | 0.180 |
Why?
|
| Patient Admission | 1 | 2021 | 113 | 0.180 |
Why?
|
| Triage | 1 | 2021 | 118 | 0.180 |
Why?
|
| Prevalence | 2 | 2021 | 1251 | 0.170 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2021 | 94 | 0.170 |
Why?
|
| Acute Disease | 4 | 2020 | 854 | 0.170 |
Why?
|
| Spinal Cord Diseases | 2 | 2012 | 29 | 0.170 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2023 | 224 | 0.170 |
Why?
|
| Spinal Injuries | 1 | 2020 | 23 | 0.170 |
Why?
|
| Central Nervous System Diseases | 1 | 2020 | 52 | 0.170 |
Why?
|
| Qualitative Research | 1 | 2021 | 312 | 0.170 |
Why?
|
| Hypercapnia | 2 | 2020 | 45 | 0.170 |
Why?
|
| Carbon Dioxide | 1 | 2020 | 205 | 0.170 |
Why?
|
| Hematologic Diseases | 1 | 2020 | 78 | 0.170 |
Why?
|
| Resource Allocation | 1 | 2020 | 65 | 0.170 |
Why?
|
| Adolescent | 4 | 2025 | 9353 | 0.160 |
Why?
|
| Patient Participation | 1 | 2021 | 227 | 0.160 |
Why?
|
| Sodium | 1 | 2020 | 334 | 0.160 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 132 | 0.160 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2020 | 78 | 0.160 |
Why?
|
| Morals | 1 | 2020 | 97 | 0.160 |
Why?
|
| Electroencephalography | 1 | 2023 | 759 | 0.160 |
Why?
|
| Vascular Diseases | 1 | 2020 | 120 | 0.160 |
Why?
|
| Hypothyroidism | 1 | 2020 | 248 | 0.150 |
Why?
|
| Drainage | 1 | 2019 | 166 | 0.150 |
Why?
|
| Health Status Disparities | 1 | 2020 | 193 | 0.150 |
Why?
|
| Patient Selection | 2 | 2012 | 682 | 0.150 |
Why?
|
| Patient Readmission | 1 | 2022 | 357 | 0.150 |
Why?
|
| Clinical Competence | 1 | 2023 | 796 | 0.150 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 6812 | 0.150 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 1735 | 0.150 |
Why?
|
| Health Personnel | 1 | 2020 | 215 | 0.140 |
Why?
|
| Value of Life | 1 | 2017 | 22 | 0.140 |
Why?
|
| Cerebral Ventricles | 1 | 2017 | 79 | 0.140 |
Why?
|
| Cohort Studies | 2 | 2021 | 2893 | 0.140 |
Why?
|
| Fibrinolytic Agents | 3 | 2017 | 231 | 0.140 |
Why?
|
| ROC Curve | 2 | 2016 | 781 | 0.140 |
Why?
|
| Meningioma | 1 | 2017 | 62 | 0.130 |
Why?
|
| Meningeal Neoplasms | 1 | 2017 | 66 | 0.130 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 2407 | 0.130 |
Why?
|
| Physician-Patient Relations | 1 | 2021 | 625 | 0.130 |
Why?
|
| Glasgow Outcome Scale | 1 | 2016 | 7 | 0.130 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2016 | 20 | 0.130 |
Why?
|
| Trauma Severity Indices | 1 | 2016 | 44 | 0.130 |
Why?
|
| Professional-Family Relations | 1 | 2016 | 54 | 0.130 |
Why?
|
| Data Display | 1 | 2015 | 23 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 321 | 0.120 |
Why?
|
| Incidence | 1 | 2020 | 1594 | 0.120 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 397 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 307 | 0.120 |
Why?
|
| Texas | 1 | 2015 | 116 | 0.120 |
Why?
|
| Area Under Curve | 1 | 2016 | 338 | 0.120 |
Why?
|
| Palliative Care | 1 | 2017 | 264 | 0.120 |
Why?
|
| Myocardium | 1 | 2018 | 574 | 0.120 |
Why?
|
| Hydrocephalus | 1 | 2016 | 105 | 0.120 |
Why?
|
| Hospitalization | 1 | 2021 | 899 | 0.120 |
Why?
|
| Heart | 1 | 2018 | 580 | 0.120 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 153 | 0.120 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2017 | 300 | 0.120 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2015 | 60 | 0.120 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2015 | 52 | 0.120 |
Why?
|
| Child | 2 | 2023 | 7216 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2016 | 276 | 0.110 |
Why?
|
| Biomarkers | 1 | 2021 | 1797 | 0.110 |
Why?
|
| Brain Diseases | 1 | 2015 | 188 | 0.110 |
Why?
|
| Data Collection | 1 | 2015 | 377 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 2782 | 0.110 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2013 | 1 | 0.110 |
Why?
|
| Levofloxacin | 1 | 2013 | 8 | 0.110 |
Why?
|
| Quadriplegia | 1 | 2013 | 23 | 0.110 |
Why?
|
| Prostatitis | 1 | 2013 | 13 | 0.110 |
Why?
|
| Cytokines | 1 | 2017 | 813 | 0.110 |
Why?
|
| Calcium Channel Blockers | 1 | 2013 | 121 | 0.110 |
Why?
|
| Neurologic Examination | 1 | 2013 | 120 | 0.110 |
Why?
|
| Radiography | 1 | 2015 | 809 | 0.100 |
Why?
|
| Pancreatitis | 1 | 2013 | 87 | 0.100 |
Why?
|
| Animals | 3 | 2023 | 27691 | 0.100 |
Why?
|
| Brain Hemorrhage, Traumatic | 1 | 2012 | 2 | 0.100 |
Why?
|
| Infusions, Intravenous | 1 | 2013 | 419 | 0.100 |
Why?
|
| South Carolina | 1 | 2011 | 3 | 0.100 |
Why?
|
| Infarction | 1 | 2012 | 27 | 0.100 |
Why?
|
| Logistic Models | 1 | 2016 | 1216 | 0.100 |
Why?
|
| Latin America | 2 | 2023 | 14 | 0.100 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 199 | 0.100 |
Why?
|
| Pyridines | 1 | 2013 | 303 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 866 | 0.090 |
Why?
|
| Diuretics, Osmotic | 1 | 2011 | 2 | 0.090 |
Why?
|
| Antihypertensive Agents | 1 | 2013 | 258 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2016 | 413 | 0.090 |
Why?
|
| Perfusion Imaging | 1 | 2011 | 50 | 0.090 |
Why?
|
| Health Status Indicators | 1 | 2011 | 103 | 0.090 |
Why?
|
| Siblings | 1 | 2011 | 106 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2017 | 3486 | 0.090 |
Why?
|
| Endovascular Procedures | 2 | 2012 | 297 | 0.090 |
Why?
|
| Kidney Diseases | 1 | 2013 | 321 | 0.090 |
Why?
|
| Myocardial Stunning | 1 | 2010 | 12 | 0.090 |
Why?
|
| Thrombectomy | 1 | 2012 | 193 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2011 | 279 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2013 | 722 | 0.090 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2012 | 275 | 0.080 |
Why?
|
| Europe | 2 | 2021 | 328 | 0.080 |
Why?
|
| Puerperal Disorders | 1 | 2009 | 32 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 100 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1935 | 0.080 |
Why?
|
| Survival Rate | 1 | 2013 | 1899 | 0.080 |
Why?
|
| Kidney Transplantation | 1 | 2015 | 860 | 0.080 |
Why?
|
| Anemia, Pernicious | 1 | 2008 | 2 | 0.080 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2008 | 7 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 566 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 806 | 0.070 |
Why?
|
| Hypertension | 1 | 2013 | 746 | 0.070 |
Why?
|
| Nitrous Oxide | 1 | 2008 | 106 | 0.070 |
Why?
|
| Clinical Protocols | 2 | 2020 | 158 | 0.070 |
Why?
|
| Anesthetics, Inhalation | 1 | 2008 | 97 | 0.070 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2008 | 90 | 0.070 |
Why?
|
| Echocardiography | 1 | 2010 | 947 | 0.060 |
Why?
|
| Heart Ventricles | 1 | 2010 | 792 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2021 | 875 | 0.050 |
Why?
|
| Reference Standards | 1 | 2023 | 143 | 0.050 |
Why?
|
| Swine | 1 | 2023 | 593 | 0.050 |
Why?
|
| Brain Stem | 1 | 2022 | 167 | 0.050 |
Why?
|
| Head Injuries, Closed | 1 | 2020 | 12 | 0.050 |
Why?
|
| Surgical Mesh | 1 | 2002 | 125 | 0.050 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2021 | 168 | 0.050 |
Why?
|
| Hernia, Inguinal | 1 | 2002 | 76 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2020 | 64 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 81 | 0.040 |
Why?
|
| Heart Failure | 1 | 2010 | 1270 | 0.040 |
Why?
|
| Oceania | 1 | 2020 | 5 | 0.040 |
Why?
|
| Personnel Management | 1 | 2020 | 7 | 0.040 |
Why?
|
| Middle East | 1 | 2020 | 18 | 0.040 |
Why?
|
| Respiratory Therapy | 1 | 2020 | 14 | 0.040 |
Why?
|
| Asia | 1 | 2020 | 103 | 0.040 |
Why?
|
| Pharmacists | 1 | 2020 | 35 | 0.040 |
Why?
|
| Transportation of Patients | 1 | 2020 | 35 | 0.040 |
Why?
|
| Internationality | 1 | 2020 | 71 | 0.040 |
Why?
|
| North America | 1 | 2020 | 188 | 0.040 |
Why?
|
| Survivors | 1 | 2020 | 191 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 271 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2020 | 281 | 0.040 |
Why?
|
| Neurology | 1 | 2020 | 75 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 129 | 0.040 |
Why?
|
| Neurosurgery | 1 | 2020 | 105 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 476 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 338 | 0.040 |
Why?
|
| Inpatients | 1 | 2021 | 313 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2017 | 152 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2017 | 224 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 387 | 0.040 |
Why?
|
| Blindness, Cortical | 1 | 2017 | 8 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 1074 | 0.030 |
Why?
|
| Comorbidity | 1 | 2021 | 955 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2017 | 255 | 0.030 |
Why?
|
| Leukocytes | 1 | 2017 | 209 | 0.030 |
Why?
|
| Craniotomy | 1 | 2017 | 89 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 1485 | 0.030 |
Why?
|
| Chicago | 1 | 2020 | 1440 | 0.030 |
Why?
|
| United States | 2 | 2022 | 7142 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 431 | 0.030 |
Why?
|
| Glucose | 1 | 2017 | 633 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 788 | 0.030 |
Why?
|
| Time-to-Treatment | 1 | 2015 | 125 | 0.030 |
Why?
|
| Infarction, Anterior Cerebral Artery | 1 | 2012 | 2 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2013 | 591 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2012 | 62 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 680 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 303 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2020 | 1066 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 2011 | 109 | 0.020 |
Why?
|
| Medicine | 1 | 2011 | 91 | 0.020 |
Why?
|
| Headache Disorders, Primary | 1 | 2009 | 3 | 0.020 |
Why?
|
| Analgesics | 1 | 2009 | 119 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2009 | 153 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 1919 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2008 | 31 | 0.020 |
Why?
|
| Vitamin B 12 | 1 | 2008 | 24 | 0.020 |
Why?
|
| Leg | 1 | 2008 | 140 | 0.020 |
Why?
|
| Pregnancy | 1 | 2009 | 3064 | 0.010 |
Why?
|